DRUG · Mapped RxNorm record
Exenatide
Normalized identity: exenatideView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy
NCT02690883
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Lispro
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedEffect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Diabetic Nephropathiesunresolved
Interventions
ExenatideDRUG · verified · RxNorm: exenatide
LisproDRUG
Sponsors & collaborators
Nanfang Hospital, Southern Medical Universitylead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02690883 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.